Warren Averett Asset Management LLC Has $1.54 Million Position in CVS Health Corp (NYSE:CVS)

Warren Averett Asset Management LLC grew its position in shares of CVS Health Corp (NYSE:CVS) by 12.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,880 shares of the pharmacy operator’s stock after buying an additional 2,120 shares during the period. Warren Averett Asset Management LLC’s holdings in CVS Health were worth $1,535,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in CVS. Private Advisor Group LLC increased its stake in CVS Health by 231.6% in the 1st quarter. Private Advisor Group LLC now owns 132,340 shares of the pharmacy operator’s stock worth $7,388,000 after acquiring an additional 92,431 shares during the last quarter. Roof Eidam & Maycock ADV bought a new position in CVS Health in the 1st quarter worth about $1,649,000. Pinnacle Associates Ltd. increased its stake in CVS Health by 12.7% in the 1st quarter. Pinnacle Associates Ltd. now owns 227,377 shares of the pharmacy operator’s stock worth $17,849,000 after acquiring an additional 25,687 shares during the last quarter. Brandes Investment Partners LP bought a new position in CVS Health in the 1st quarter worth about $7,401,000. Finally, Hayek Kallen Investment Management increased its stake in CVS Health by 6.5% in the 1st quarter. Hayek Kallen Investment Management now owns 14,425 shares of the pharmacy operator’s stock worth $1,132,000 after acquiring an additional 882 shares during the last quarter. Institutional investors own 81.62% of the company’s stock.

Several equities analysts have recently commented on the company. Royal Bank of Canada assumed coverage on CVS Health in a research report on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price objective on the stock. Jefferies Group increased their price objective on CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research report on Friday, September 15th. ValuEngine lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Leerink Swann increased their price objective on CVS Health from $82.00 to $90.00 and gave the company an “outperform” rating in a research report on Monday. Finally, Robert W. Baird reiterated a “hold” rating and set a $77.00 price objective on shares of CVS Health in a research report on Friday, October 27th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $86.66.

In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.61% of the stock is owned by company insiders.

CVS Health Corp (NYSE CVS) traded up $0.74 during midday trading on Thursday, reaching $78.18. The company’s stock had a trading volume of 457,655 shares, compared to its average volume of 10,810,000. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.72. The stock has a market cap of $79,170.00, a PE ratio of 16.15, a P/E/G ratio of 1.38 and a beta of 0.90. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. During the same quarter in the prior year, the company earned $1.64 EPS. The business’s revenue was up 3.5% compared to the same quarter last year. equities analysts forecast that CVS Health Corp will post 5.9 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.56%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 41.32%.

COPYRIGHT VIOLATION NOTICE: “Warren Averett Asset Management LLC Has $1.54 Million Position in CVS Health Corp (NYSE:CVS)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was illegally copied and republished in violation of US & international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/01/11/cvs-health-corp-cvs-stake-boosted-by-warren-averett-asset-management-llc.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply